Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated to reflect a new version of a study on multiple myeloma, including a change in the revision number and the removal of specific details about the study's purpose and inclusion/exclusion criteria.SummaryDifference15%
- Check47 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check90 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check105 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check112 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.